MediPrint® Ophthalmics (MediPrint), a clinical-stage ophthalmic drug delivery company based in San Diego, announced the results of the Company’s Phase 2b clinical trial of LL-BMT1. Employing a novel ...

Revealing an urgency for long-term myopia management LONDON, Nov. 12, 2024 /PRNewswire/ -- A new Ipsos survey[1] commissioned by Essilor® Stellest® lenses amongst 1,000 UK parents has revealed ...

The poll highlighted huge gaps in knowledge amongst parents around myopia: The vast majority of parents of myopic children (94%) wrongly believe that having their myopic child wear glasses or contact ...

A drug-eluting contact lens that uses 3D printing technology can improve IOP and treatment compliance for patients with glaucoma.